Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2161 AL 2175

Blood biomarkers for Alzheimer's disease and related disorders

Zetterberg H, Schott JM.

Acta Neurol Scand. 2022 Jul;146(1):51-55. doi: 10.1111/ane.13628. Epub 2022 Apr 25.

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, Skordos L, Tian Y, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A.

J Prev Alzheimers Dis. 2022;9(2):197-210. doi: 10.14283/jpad.2022.30.

Effects of interventions on cerebral perfusion in the Alzheimer's disease spectrum: A systematic review

Marcolini S, Frentz I, Sanchez-Catasus CA, Mondragon JD, Feltes PK, van der Hoorn A, Borra RJH, Ikram MA, Dierckx RAJO, De Deyn PP.

Ageing Res Rev. 2022 Aug;79:101661. doi: 10.1016/j.arr.2022.101661. Epub 2022 Jun 4.

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention

Li T, Lu L, Pember E, Li X, Zhang B, Zhu Z.

Cells. 2022 Jun 14;11(12):1925. doi: 10.3390/cells11121925.

Tau as a Biomarker of Neurodegeneration

Holper S, Watson R, Yassi N.

Int J Mol Sci. 2022 Jun 30;23(13):7307. doi: 10.3390/ijms23137307.

Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity

Zicha S, Bateman RJ, Shaw LM, Zetterberg H, Bannon AW, Horton WA, Baratta M, Kolb HC, Dobler I, Mordashova Y, Saad ZS, Raunig DL, Spanakis EM, Li Y, Schindler SE, Ferber K, Rubel CE, Martone RL, Weber CJ, Edelmayer RM, Meyers EA, Bollinger JG, Rosenbaugh EG, Potter WZ; Alzheimer's Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ as a Predictor of Amyloid Positivity in Alzheimer's Disease Project Team.

Alzheimers Dement. 2023 Mar;19(3):956-966. doi: 10.1002/alz.12697. Epub 2022 Jul 12.

Insights for Alzheimer's disease pharmacotherapy and current clinical trials

Nascimento ALCS, Fernandes RP, Carvalho ACS, Frigieri I, Alves RC, Chorilli M.

Neurochem Int. 2022 Oct;159:105401. doi: 10.1016/j.neuint.2022.105401. Epub 2022 Jul 13.

Biomarkers for Alzheimer's Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation

Cummings J, Kinney J.

Medicina (Kaunas). 2022 Jul 19;58(7):952. doi: 10.3390/medicina58070952.

Association between Human Blood Metabolome and the Risk of Alzheimer's Disease

Sun L, Guo D, Jia Y, Shi M, Yang P, Wang Y, Liu F, Chen GC, Zhang Y, Zhu Z.

Ann Neurol. 2022 Nov;92(5):756-767. doi: 10.1002/ana.26464. Epub 2022 Aug 15.

Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease

Prins S, de Kam ML, Teunissen CE, Groeneveld GJ.

Alzheimers Res Ther. 2022 Aug 3;14(1):106. doi: 10.1186/s13195-022-01051-2.

Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer's disease

Vandendriessche C, Kapogiannis D, Vandenbroucke RE.

Adv Drug Deliv Rev. 2022 Nov;190:114486. doi: 10.1016/j.addr.2022.114486. Epub 2022 Aug 8.

Exploring Plausible Therapeutic Targets for Alzheimer's Disease using Multi-omics Approach, Machine Learning and Docking

Parvathy Dharshini SA, Sneha NP, Yesudhas D, Kulandaisamy A, Rangaswamy U, Shanmugam A, Taguchi YH, Gromiha MM.

Curr Top Med Chem. 2022;22(22):1868-1879. doi: 10.2174/1568026622666220902110115.

Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, Zettergren A, Mishra A, Ali M, Andrade V, Bellenguez C, Kleineidam L, Küçükali F, Sung YJ, Tesí N, Vromen EM, Wightman DP, Alcolea D, Alegret M, Alvarez I, Amouyel P, Athanasiu L, Bahrami S, Bailly H, Belbin O, Bergh S, Bertram L, Biessels GJ, Blennow K, Blesa R, Boada M, Boland A, Buerger K, Carracedo Á, Cervera-Carles L, Chene G, Claassen JAHR, Debette S, Deleuze JF, de Deyn PP, Diehl-Schmid J, Djurovic S, Dols-Icardo O, Dufouil C, Duron E, Düzel E; EADB consortium; Fladby T, Fortea J, Frölich L, García-González P, Garcia-Martinez M, Giegling I, Goldhardt O, Gobom J, Grimmer T, Haapasalo A, Hampel H, Hanon O, Hausner L, Heilmann-Heimbach S, Helisalmi S, Heneka MT, Hernández I, Herukka SK, Holstege H, Jarholm J, Kern S, Knapskog AB, Koivisto AM, Kornhuber J, Kuulasmaa T, Lage C, Laske C, Leinonen V, Lewczuk P, Lleó A, de Munain AL, Lopez-Garcia S, Maier W, Marquié M, Mol MO, Montrreal L, Moreno F, Moreno-Grau S, Nicolas G, Nöthen MM, Orellana A, Pålhaugen L, Papma JM, Pasquier F, Perneczky R, Peters O, Pijnenburg YAL, Popp J, Posthuma D, Pozueta A, Priller J, Puerta R, Quintela I, et al.

Acta Neuropathol. 2022 Nov;144(5):821-842. doi: 10.1007/s00401-022-02454-z. Epub 2022 Sep 6.

Demand Coupling Drives Neurodegeneration: A Model of Age-Related Cognitive Decline and Dementia

Turknett J, Wood TR.

Cells. 2022 Sep 7;11(18):2789. doi: 10.3390/cells11182789.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias